Published in Clin Cancer Res on March 01, 2002
Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C. Proc Natl Acad Sci U S A (2005) 1.10
Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia (2009) 0.97
Chicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomas. PLoS One (2012) 0.87
The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer. Biochem Biophys Res Commun (2007) 0.85
Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis. J Biol Chem (2012) 0.82
PTN signaling: Components and mechanistic insights in human ovarian cancer. Mol Carcinog (2014) 0.82
Pleiotrophin promotes perineural invasion in pancreatic cancer. World J Gastroenterol (2013) 0.81
Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis. Dig Dis Sci (2008) 0.81
mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray. World J Gastroenterol (2006) 0.81
Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells. Biochem Biophys Res Commun (2006) 0.79
The colorectal microRNAome. Proc Natl Acad Sci U S A (2006) 11.59
Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A (2005) 5.91
Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol (2009) 2.34
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci Signal (2014) 1.61
Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Biol Chem (2002) 1.58
The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res (2008) 1.53
Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene (2003) 1.43
RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension (2006) 1.41
Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res Treat (2004) 1.41
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget (2012) 1.33
The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res (2004) 1.32
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle (2012) 1.32
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer. Breast Cancer Res Treat (2009) 1.29
Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J Biol Chem (2002) 1.25
Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res (2004) 1.24
Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res (2007) 1.21
Retracted Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol Endocrinol (2003) 1.19
Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One (2011) 1.12
Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Mol Cell Biol (2008) 1.11
Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology (2008) 1.10
E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res (2006) 1.08
Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J Biol Chem (2002) 1.07
Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity. Oncogene (2004) 1.03
p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice. Hypertension (2011) 1.02
Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension (2011) 1.02
Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization. Methods (2006) 1.02
Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse. Front Genet (2013) 0.99
Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome. Am J Physiol Regul Integr Comp Physiol (2006) 0.98
Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. Lab Invest (2005) 0.97
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget (2014) 0.97
Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol (2012) 0.93
Omics-based molecular target and biomarker identification. Methods Mol Biol (2011) 0.93
Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. PLoS One (2011) 0.93
A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells. Oncogene (2002) 0.92
A prospective study of kitesurfing injuries. Am J Sports Med (2004) 0.92
Effects on neurite outgrowth and cell survival of a secreted fibroblast growth factor binding protein upregulated during spinal cord injury. Am J Physiol Regul Integr Comp Physiol (2007) 0.89
Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res (2006) 0.89
Retracted Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway. Oncogene (2003) 0.89
Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. Am J Pathol (2011) 0.89
A distinct role for secreted fibroblast growth factor-binding proteins in development. Proc Natl Acad Sci U S A (2009) 0.89
Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. Clin Exp Metastasis (2002) 0.89
Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res (2003) 0.89
Facial attractiveness: visual impact of symmetry increases significantly towards the midline. Ann Plast Surg (2007) 0.89
Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis. Cancer Res (2003) 0.88
Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. J Biol Chem (2005) 0.86
Regenerative treatment of peri-implantitis bone defects with a combination of autologous bone and a demineralized xenogenic bone graft: a series of 36 defects. Clin Implant Dent Relat Res (2010) 0.86
Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. Neoplasia (2004) 0.85
Effect of FGF-binding protein 3 on vascular permeability. J Biol Chem (2008) 0.84
Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. Am J Pathol (2012) 0.83
Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development. Histochem Cell Biol (2001) 0.83
The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma. Semin Oncol (2006) 0.83
Systemic morphine administration suppresses genes involved in antigen presentation. Mol Pharmacol (2004) 0.82
Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels. Proteomics Clin Appl (2007) 0.82
Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription. J Biol Chem (2011) 0.81
Surface expression and CEA binding of hnRNP M4 protein in HT29 colon cancer cells. Anticancer Res (2005) 0.80
A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest. J Virol (2012) 0.79
Gender and nasal shape: measures for rhinoplasty. Plast Reconstr Surg (2008) 0.79
Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells. Mol Endocrinol (2013) 0.78
Platform for Personalized Oncology: Integrative analyses reveal novel molecular signatures associated with colorectal cancer relapse. AMIA Jt Summits Transl Sci Proc (2013) 0.78
Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -. Cancer Res Treat (2006) 0.78
Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells. PLoS One (2012) 0.78
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. BMC Genomics (2015) 0.77
Hunting ALK to feed targeted cancer therapy. Nat Med (2011) 0.76
Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex. Mol Endocrinol (2014) 0.75
Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway. Oncogene (2005) 0.75
[Facial aesthetics Part II - effect of symmetric and asymmetric modulations of the orbital region]. Mund Kiefer Gesichtschir (2007) 0.75
[Facial aesthetics part I - the significance of the triangle of yarbus]. Mund Kiefer Gesichtschir (2007) 0.75
What improvements would you recommend in the collection of control samples? Biopreserv Biobank (2011) 0.75
Nasal shape and gender of the observer: implications for rhinoplasty. J Craniomaxillofac Surg (2008) 0.75
Determination of phosphorylated proteins in tissue specimens requires high-quality samples collected under stringent conditions. Histopathology (2013) 0.75